Illumina GSA-MD v3 genotyping arrays for 183 samples
Genotyping arrays for 183 samples from patients with a neuroendocrine tumor of the small intestine. All samples have been hybridized on Illumina GSA-MD v3 arrays with standard automated protocols. Reading of the chips was performed on Illumina iScan+ scanners and this file is the result of primary analysis done using Illumina GenomeStudio software. It contains data for 147 tumors, 2 adenomas, 1 lymph node, 19 mesenteric nodules, 6 liver metastasis and 8 normal ileum samples.
- 20/12/2024
- 183 samples
- DAC: EGAC50000000218
- Technology: unspecified
- IRB DUO:0000021 (version: 2021-02-23)ethics approval requiredThis data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.ModifiersPlease provide details project synopsis for review by ethical / GDPR / Scientific Committee
- GS DUO:0000022 (version: 2021-02-23)geographical restrictionThis data use modifier indicates that use is limited to within a specific geographic region.ModifiersRestriction of use within countries enforcing a strict Patient Data / Personal Data Protection Regulation such as EU GDPR or EU approved countries
- MOR DUO:0000024 (version: 2021-02-23)publication moratoriumThis data use modifier indicates that requestor agrees not to publish results of studies until a specific date.Modifiersall publications of project results involving direct or indirect use of the results must acknowledge the contribution support of : "Centre Leon Berard - CLB - Comprehensive Cancer Center, Lyon France" "Cancer Research Center of Lyon - CRCL - U1052 - UMR5286, Lyon France"
- TS DUO:0000025 (version: 2021-02-23)time limit on useThis data use modifier indicates that use is approved for a specific number of months.Modifiers2 years maximum Exceptions possible in specific cases if approved by ethical committee
- RTN DUO:0000029 (version: 2021-02-23)return to database or resourceThis data use modifier indicates that the requestor must return derived/enriched data to the database/resource.ModifiersUser shall provide a short summary report of its results to the dataset supplier for patient transparency purpose
- NPOA DUO:0000044 (version: 2021-02-23)population origins or ancestry research prohibitedThis data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited.
- NCU DUO:0000046 (version: 2021-02-23)non-commercial use onlyThis data use modifier indicates that use of the data is limited to not-for-profit use.
Non commercial research only - GDPR compliant
Non Commercial Use only Please provide details project synopsis for review by ethical / GDPR / Scientific Committee - Prefered projects : Cancers, Digestive Diseases, Rare Diseases Restriction of use within countries enforcing a strict Patient Data / Personal Data Protection Regulation such as EU GDPR or EU approved countries 2 years maximum use - Exceptions possible in specific cases if approved by ethical committee All publications of project results involving direct or indirect use of the results must acknowledge the contribution support of : "Centre Leon Berard - CLB - Comprehensive Cancer Center, Lyon France" "Cancer Research Center of Lyon - CRCL - U1052 - UMR5286, Lyon France" User shall provide a short summary report of its results to the dataset supplier for patient transparency purpose Population origins or ancestry research prohibited
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS50000000642 | Cancer Genomics |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Located in | |
|---|---|---|---|---|
| EGAF50000216467 | cnv.gz | 2.5 GB | ||
| 1 File (2.5 GB) | ||||